Isothermal Nucleic Acid Amplification Technology (INAAT) Market, by Product Type (Instruments and Reagents & Kits), by Technology (Helicase Dependent Amplification (HAD),  Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence-based Amplific

Isothermal Nucleic Acid Amplification Technology (INAAT) Market, by Product Type (Instruments and Reagents & Kits), by Technology (Helicase Dependent Amplification (HAD),  Nicking Enzyme Amplification Reaction (NEAR), Nucleic Acid Sequence-based Amplification (NASBNA), Transcription Medicated Amplification (TMA), Single Primer Isothermal Amplification (SPIA), and Loop-mediated Isothermal Amplification (LAMP)), by Application (Infectious Disease Diagnostics, Blood Screening, Others), by End User (Academic and Research Institutes, Diagnostic Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Isothermal nucleic acid technologies have applications in the field of recombinant DNA and molecular biology techniques. These techniques are used in the detection and analysis of small quantity of nucleic acids. Polymerase chain reaction is based on isothermal nucleic acid amplification technology. The polymerase chain reaction (PCR) is most widely used method for DNA amplification. Polymerase chain reaction (PCR) is used for the detection and identification of infectious diseases, genetic disorders, and for research purposes. PCR consists of thermocycling machine, which facilitates separation and amplification of DNA strands.
Market Dynamics
Increasing approvals from healthcare regulatory authorities for innovative technologies is expected to drive the global isothermal nucleic acid amplification technology (INAAT) market growth
For instance, in October 2021, Abbott laboratories received the U.S. Food and Drug Administration (FDA) for its next-generation Influenza A & B2 and Strep A2 molecular assays. These assays are used for the molecular detection and differentiation of influenza A and B virus. Next-generation Influenza A & B2 and Strep A2 molecular assays are currently available on ID NOW platform, which is a rapid isothermal system. It is used for the detection of infectious diseases such as influenza.
Rising product launches by key players is expected to boost the global isothermal nucleic acid amplification technology (INAAT) market growth
For instance, in July 2017, TwistDx Inc. launched TwistAmp, a recombinase polymerase amplification (RPA) kit. It is used for DNA/RNA amplification. TwistAmp is an isothermal alternative to polymerase chain reaction PCR.
Key features of the study:
This report provides in-depth analysis of the global isothermal nucleic acid amplification technology (INAAT) market size (US$ Mn), and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global isothermal nucleic acid amplification technology (INAAT) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global isothermal nucleic acid amplification technology (INAAT) market report caters to various stakeholders in this industry including investors, product manufacturers, distributors, and suppliers for isothermal nucleic acid amplification technology (INAAT) market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type:
Instruments
Reagents & Kits
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application:
Infectious Disease Diagnostics
Blood Screening
Others
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Technology:
Helicase Dependent Amplification (HAD)
Nicking Enzyme Amplification Reaction (NEAR)
Nucleic Acid Sequence Based Amplification (NASBA)
Transcription Medicated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Loop-mediated Isothermal Amplification (LAMP)
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By End User:
Academic and Research Institutes
Diagnostic Laboratories
Others
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market , By Region:
North America
By Product Type:
Instruments
Reagents & Kits
By Technology:
Helicase Dependent Amplification (HAD)
Nicking Enzyme Amplification Reaction (NEAR)
Nucleic Acid Sequence Based Amplification (NASBA)
Transcription Medicated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Loop-mediated Isothermal Amplification (LAMP)
By Application:
Infectious Disease Diagnostics
Blood Screening
Others
By End User:
Academic and Research Institutes
Diagnostic Laboratories
Others
By Country:
U.S.
Canada
Europe
By Product Type:
Instruments
Reagents & Kits
By Technology:
Helicase Dependent Amplification (HAD)
Nicking Enzyme Amplification Reaction (NEAR)
Nucleic Acid Sequence Based Amplification (NASBA)
Transcription Medicated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Loop-mediated Isothermal Amplification (LAMP)
By Application:
Infectious Disease Diagnostics
Blood Screening
Others
By End User:
Academic and Research Institutes
Diagnostic Laboratories
Others
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Product Type:
Instruments
Reagents & Kits
By Technology
Helicase Dependent Amplification (HAD)
Nicking Enzyme Amplification Reaction (NEAR)
Nucleic Acid Sequence Based Amplification (NASBA)
Transcription Medicated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Loop-mediated Isothermal Amplification (LAMP)
By Application:
Infectious Disease Diagnostics
Blood Screening
Others
By End User:
Academic and Research Institutes
Diagnostic Laboratories
Others
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
Latin America
By Product Type:
Instruments
Reagents & Kits
By Technology:
Helicase Dependent Amplification (HAD)
Nicking Enzyme Amplification Reaction (NEAR)
Nucleic Acid Sequence Based Amplification (NASBA)
Transcription Medicated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Loop-mediated Isothermal Amplification (LAMP)
By Application:
Infectious Disease Diagnostics
Blood Screening
Others
By End User:
Academic and Research Institutes
Diagnostic Laboratories
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
By Product Type:
Instruments
Reagents & Kits
By Technology:
Helicase Dependent Amplification (HAD)
Nicking Enzyme Amplification Reaction (NEAR)
Nucleic Acid Sequence Based Amplification (NASBA)
Transcription Medicated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Loop-mediated Isothermal Amplification (LAMP)
By Application:
Infectious Disease Diagnostics
Blood Screening
Others
By End User:
Academic and Research Institutes
Diagnostic Laboratories
Others
By Country:
GCC Countries
Israel
Rest of Middle East
Africa
By Product Type:
Instruments
Reagents & Kits
By Technology:
Helicase Dependent Amplification (HAD)
Nicking Enzyme Amplification Reaction (NEAR)
Nucleic Acid Sequence Based Amplification (NASBA)
Transcription Medicated Amplification (TMA)
Single Primer Isothermal Amplification (SPIA)
Loop-mediated Isothermal Amplification (LAMP)
By Application:
Infectious Disease Diagnostics
Blood Screening
Others
By End User:
Academic and Research Institutes
Diagnostic Laboratories
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Alere Inc.,*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Becton, Dickinson & Company
BioHelix Corporation
BioMerieux Biotechnology Company
Hologic Gene-Probe
QIAGEN Company
Thermo Fisher Scientific, Inc.
Lucigen Corporation
Quidel Corporation
NuGEN
“*” marked represents similar segmentation in other categories in the respective section.